A Win For Adaptimmune Therapeutics plc
Wed, Oct 08, 2025 at 07:54 PM
Adaptimmune Therapeutics plc (ADAP:NASDAQ) shot up at $0.21, a gain of 51.9%. On Wed, Oct 08, 2025, ADAP:NASDAQ hit a New 2-Week High of $0.21. From Wed, Sep 24, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jul 24, 2025 at $0.36 with a volume of 3M+.
About Adaptimmune Therapeutics plc (ADAP:NASDAQ)
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.
Top 10 Gainers:
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 141.49%
- Nexalin Technology, Inc. (NXL:NASDAQ), 98.25%
- AlphaTON Capital Corp Shs (New) (ATON:NASDAQ), 95.52%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 89.25%
- Universe Pharmaceuticals INC (UPC:NASDAQ), 82.98%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 51.88%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 46.43%
- TNL Mediagene (TNMG:NASDAQ), 45.5%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 39.41%